Associations between neurodegenerative plasma biomarkers and cognitive functioning and decline in India

Abstract

Background: Mounting evidence supports the use of blood‐based neurodegenerative biomarkers as a low‐cost, minimally invasive tool for studying dementia, but existing data largely come from clinical samples or high‐income settings.